Luxembourg: Medicaments Containing Insulin Market 2025

Medicaments Containing Insulin Market Size in Luxembourg

After two years of decline, the Luxembourg medicaments containing insulin market increased by 0.4% to $X in 2021. Overall, consumption recorded a perceptible setback. As a result, consumption attained the peak level of $X. From 2019 to 2021, the growth of the market failed to regain momentum.

Medicaments Containing Insulin Production in Luxembourg

In value terms, medicaments containing insulin production amounted to $X in 2021 estimated in export price. The total output value increased at an average annual rate of +1.2% from 2012 to 2021; the trend pattern remained relatively stable, with somewhat noticeable fluctuations being observed throughout the analyzed period. The most prominent rate of growth was recorded in 2016 when the production volume increased by 31%. As a result, production attained the peak level of $X. From 2017 to 2021, production growth remained at a lower figure.

Medicaments Containing Insulin Exports

Exports from Luxembourg

Medicaments containing insulin exports from Luxembourg was estimated at X kg in 2019, approximately equating the year before. Overall, exports showed a remarkable increase. The smallest decline of 99.9% was in 2013. The exports peaked in 2019 and are likely to continue growth in the immediate term.

In value terms, medicaments containing insulin exports stood at $X in 2019. Over the period under review, exports recorded a dramatic contraction. The smallest decline of 99.9% was in 2013. The exports peaked at $X in 2012; however, from 2013 to 2019, the exports stood at a somewhat lower figure.

Exports by Country

Congo (X kg) was the main destination for medicaments containing insulin exports from Luxembourg, with a 85% share of total exports. Moreover, medicaments containing insulin exports to Congo exceeded the volume sent to the second major destination, the Netherlands (X kg), sixfold.

From 2012 to 2019, the average annual rate of growth in terms of volume to Congo was relatively modest.

From 2012 to 2019, the average annual rate of growth in terms of value to Congo was relatively modest.

Export Prices by Country

The average medicaments containing insulin export price stood at $X per ton in 2019, stabilizing at the previous year. Overall, the export price continues to indicate a dramatic shrinkage. The pace of growth was the most pronounced in 2013 when the average export price decreased by 99.9% against the previous year. The export price peaked at $X per ton in 2012; however, from 2013 to 2019, the export prices failed to regain momentum.

There were significant differences in the average prices for the major foreign markets. In 2019, amid the top suppliers, the country with the highest price was the Netherlands ($X per ton), while the average price for exports to Congo totaled $X per ton.

From 2012 to 2019, the most notable rate of growth in terms of prices was recorded for supplies to the Netherlands (0.0%), while the prices for the other major destinations experienced more modest paces of growth.

Medicaments Containing Insulin Imports

Imports into Luxembourg

In 2019, overseas purchases of medicaments containing insulin but not antibiotics decreased by -27.8% to X kg for the first time since 2015, thus ending a three-year rising trend. Over the period under review, imports, however, recorded a tangible increase. The pace of growth appeared the most rapid in 2018 with an increase of 1,700%. As a result, imports attained the peak of X kg, and then declined rapidly in the following year.

In value terms, medicaments containing insulin imports contracted markedly to $X in 2019. In general, imports, however, showed a significant increase. The pace of growth was the most pronounced in 2018 with an increase of 18,400%. As a result, imports reached the peak of $X, and then reduced remarkably in the following year.

Imports by Country

In 2019, the Netherlands (X kg) was the main medicaments containing insulin supplier to Luxembourg, with a approx. 100% share of total imports.

From 2012 to 2019, the average annual rate of growth in terms of volume from the Netherlands stood at +2.4%.

In value terms, the Netherlands ($X) constituted the largest supplier of medicaments containing insulin but not antibiotics to Luxembourg.

From 2012 to 2019, the average annual rate of growth in terms of value from the Netherlands totaled +30.6%.

Import Prices by Country

The average medicaments containing insulin import price stood at $X per ton in 2019, waning by -3.1% against the previous year. Over the period under review, the import price, however, posted a significant increase. The pace of growth was the most pronounced in 2018 an increase of 984% against the previous year. As a result, import price attained the peak level of $X per ton, and then dropped modestly in the following year.

As there is only one major supplying country, the average price level is determined by prices for the Netherlands.

From 2012 to 2019, the rate of growth in terms of prices for the Netherlands amounted to +26.7% per year.

Source: IndexBox Platform

Frequently Asked Questions (FAQ) :